Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013

New York Attorney General Letitia James has sent a letter to a CBD oil company demanding that it stop advertising that its products can help fight coronavirus. James’ office sent the cease-and-desist letter to Utah company Finest Herbalist for advertising in emails, text messages and on bogus news sites that its Pure Herbal Total Defense
READ MORE
Cannabis in colorado has been changing its image as we see children using the drug as a means of treatment for epilepsy. While many medical professionals (with no experience with cbd) claim these patients are not really improving due to the effects of the cbd oil the local’s see it first hand. When three-year-olds go
READ MORE
UPDATE: Collier County Planning Commission has voted unanimously to not move forward with allowing medical marijuana dispensaries in unincorporated Collier County. The Commission voted 6-0 Thursday, citing a lack of information. The vote will now carry to the County Commission, set for an October 11th vote. If the vote is tabled due to a further
READ MORE
Clinical trials currently being conducted in Georgia to study the effects of CBD oil in patients suffering from epilepsy. There have already been some positive results suggesting that it could be quite effective as a treatment for various epileptic diseases. The study created by the states medical cannabis commission aims to determine whether or not Georgia
READ MORE
A recent clinical trial conducted in Sydney, Australia, has found that nighttime use of plant-derived cannabis oil does not result in next-day impairment for insomnia patients. The study, reported by NORML, highlights the potential benefits of cannabis oil for individuals struggling with sleep disorders. Participants in the trial used cannabis oil before bedtime and were
READ MORE
Australian researchers have published the first robust clinical study proving that medicinal cannabis effectively treats the debilitating effects of Tourette syndrome. The findings—which show a statistically and clinically significant reduction in motor and vocal tics in just six weeks—are published in the journal NEJM Evidence. The clinical trial was led by neuropsychiatrist Dr. Philip Mosley, a Research Fellow
READ MORE